Pharmachem enters US probiotics market

By Shane Starling

- Last updated on GMT

Related tags Probiotic strains Dietary supplement Vitamin

New Jersey-based Pharmachem Laboratories has inked a deal with Italian firm, Probiotical, to exclusively supply its probiotic strains to the US market – its first move into the probiotics market.

To begin with, Probiotical will supply 10-15 of its key clinically-backed strains to Pharmachem and the two companies will work closely together on formulation to develop prototypes and meet client requests. Other strains from Probiotical may be utilized at a later date.

The companies said they were working on a strain that could deliver two-year stability at 25 degrees centigrade.

Pharmachem business development manager, Gregory Bonfilio, said his company had chosen to work with Probiotical because of the strength of its clinical backing and the fact its strains were allergen-free.

“They have very strong research and development, clinical studies, characterization,” ​Bonfilio said. “They also have a number of prebiotic/probiotic combination formulas that have clinical backing and we expect these will appeal to some of our existing dietary supplement customers and potential food customers.”

Pharmachem said it would target the dietary supplements industry first, with foods and beverages following later.

Probiotical research work into non-gut health and immunity applications – such as the ability of the microbes to speed the absorption of vitamins and minerals in supplement complexes – also appealed to Pharmachem.

One study had shown a particular strain could assist the body to absorb folic acid.

“We will work closely with Probiotical to develop products and prototypes and have made some progress on a confrectionery delivery system similar to a ‘Smartie’,”​ he said.

He also praised Probiotical for the strictly characterised nature of its probiotics – something that is not always the case, he said, as some suppliers and manufacturers tend to adopt a ‘one-size-fits-all’ which does little justice to the plethora of probiotic strains and the manner in which they function in the body.

“This is key to us because the regulatory scene is not strict here in the US and so it is up to industry to ensure the ingredients are being formulated and marketed properly,” ​Bonfilio said. “But thanks to the work of companies like Dannon the market is becoming more sophisticated. They have been very aggressive and moved into new areas.”

Probiotical says it is unique among probiotic suppliers as it is the only one to hold a global patent for the removal of “every type of allergen”,​ as Probiotical sales manager, Georio Cerana, puts it.

“It doesn’t add much to the cost of the ingredient,”​ he said.

Now that Pharmachem is a probiotics supplier, it said it would be joining the International Probiotics Association (IPA), which recently moved its head offices to Switzerland.

Related news

Show more

Related products

show more

Explore New Opportunities in Postbiotics

Explore New Opportunities in Postbiotics

Content provided by CJ BIO | 21-Jun-2024 | White Paper

Explore the latest trends and versatile postbiotics to propel your brand forward. As a biotics market expert, staying ahead with innovation is crucial.

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 18-Jun-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Related suppliers

Follow us


View more